You are hereBiblio / Vioxx and the Merck Team Effort
Vioxx and the Merck Team Effort
| Title | Vioxx and the Merck Team Effort |
| Publication Type | Case Study |
| Year of Publication | 2009 |
| Authors | Presley, Holly |
| Corporate Authors | Kenan Institute for Ethics, Duke University |
| Pagination | 22 p. |
| Publisher | Kenan Institute for Ethics, Duke University |
| Publication Language | eng |
| Keywords | business , BUSINESS ethics , Consumer , Drug , FDA , marketing , Marketing Ethics , MEDICINE , Merck , MISSION , Pharmaceutical , product , Product and Consumer Safety , Regulation , Vioxx |
| Abstract | The pharmaceutical company Merck continued to market its popular prescription pain reliver, Vioxx, despite mounting concerns over its safety. This case study uses the Merck Vioxx episode to examine the coexistence of competing understandings of mission across organizational subdivisions and the difficulty of regulating drug safety in a market context. |
| URL | Click here for the document |
| Abbreviated Case Name | Vioxx and the Merck Team Effort |
